MADRID, July 24 (Reuters) - Private Spanish biotechnology company Cellerix is talking to most of the world’s big drugmakers about a tie-up that could lead to partnerships or even its eventual acquisition, its chief executive said.
MADRID, July 24 (Reuters) - Private Spanish biotechnology company Cellerix is talking to most of the world’s big drugmakers about a tie-up that could lead to partnerships or even its eventual acquisition, its chief executive said.
